Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Hepatocellular

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 530 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Recruiting

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

NCT04803994

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: LKH - Univ. Klinikum Graz Graz, Austria

Medzinische Universität Innsbruck Innsbruck, Austria

Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria

Ordensklinikum Linz Linz, Austria

View all 72 locations

View Trial Details

Recruiting

TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma

NCT06114082

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma

NCT06178198

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

NCT06446154

Conditions: Adenocarcinoma, Anti-angiogenic Therapy, Carcinoma, +12 more
Locations: Sun Yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma

NCT05613478

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance

NCT06653062

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Tongji Hospital Wuhan, Hubei, China

View Trial Details

Recruiting

The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy

NCT06746194

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Mts105 for Advanced Hepatocellular Carcinoma

NCT06689540

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Peking University Cancer Hospital Beijing, China

View Trial Details

Recruiting

18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma

NCT05871892

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Aarhus University Hospital Aarhus, Denmark

View Trial Details

Recruiting

A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma

NCT05359939

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Aarhus University Hospital Aarhus, Denmark

View Trial Details